Long-term exposure to nicotine modulates the level and activity of acetylcholine receptors in white blood cells of smokers and model mice

Molecular Pharmacology

Volumn 66, Issue 6, 2004, Pages 1712-1718

  Cormier, Anne ^a   Paas, Yoav ^a   Zini, Roland ^b   Tillement, Jean Paul ^b   Lagrue, Gilbert ^c   Changeux, Jean Pierre ^a   Grailhe, Régis ^a  

^a INSTITUT PASTEUR   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c Hopital Albert Chenevier   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE RECEPTOR ALPHA4; ACETYLCHOLINE RECEPTOR BETA2; ALPHA BUNGAROTOXIN; CALCIUM ION; CHOLINERGIC RECEPTOR; EPIBATIDINE; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ADDICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BRAIN; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LEUKOCYTE; LONG TERM EXPOSURE; MALE; MEMBRANE CHANNEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SMOKING; WILD TYPE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; KINETICS; MICE; NEUTROPHILS; NICOTINE; RECEPTORS, CHOLINERGIC; SMOKING; UP-REGULATION;

EID: 9444220284     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.000463     Document Type: Article

References (45)

1. Albuquerque EX, Pereira EF, Bonfante-Cabarcas R, Marchioro M, Matsubayashi H, Alkondon M, and Maelicke A (1996) Nicotinic acetylcholine receptors on hippocampal neurons: cell compartment-specific expression and modulatory control of channel activity. Prog Brain Res 109:111-124.
2. 3H]Nicotine binding in peripheral blood cells of smokers is correlated with the number of cigarettes smoked per day. Neuropharmacology 39:2818-2829.
3. Benowitz NL (1999) Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect 107 (Suppl 2):349-355.
4. Benowitz NL and Jacob P 3rd (1990) Intravenous nicotine replacement suppresses nicotine intake from cigarette smoking. J Pharmacol Exp Ther 254:1000-1005.
5. 3H]nicotine binding sites in human brain. J Neurochem 50:1243-1247.
6. 3H]nicotine binding in human post-mortem brain. J Pharmacol Exp Ther 50:1243-1247.
7. Buisson B and Bertrand D (2001) Chronic exposure to nicotine upregulates the human alpha4beta2 nicotinic acetylcholine receptor function. J Neurosci 21:1819-1829.
8. Buisson B and Bertrand D (2002) Nicotine addiction: the possible role of functional upregulation. Trends Pharmacol Sci 23:130-136.
9. Cabanis A, Gressier B, Lebegue S, Brunet C, Dine T, Luyckx M, Cazin M, and Cazin JC (1994) A rapid density gradient technique for separating polymorphonuclear granulocytes. APMIS 102:119-121.
10. Dani JA, Ji D, and Zhou FM (2001) Synaptic plasticity and nicotine addiction. Neuron 31:349-352.
11. Fenster CP, Whitworth TL, Sheffield EB, Quick MW, and Lester RAJ (1999) Up-regulation of surface β2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine. J Neurosci 19:4804-4814.
12. Flores CM, Rogers SW, Pabreza LA, Wolfe BB, and Keller KJ (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of α4-subunit and β2-subunit and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41:31-37.
13. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, et al. (1996) Inhibition of monoamine oxidase B in the brains of smokers. Nature (Lond) 379:733-736.
14. Grando SA, Horton RM, Pereira EF, Diethelm-Okita BM, George PM, Albuquerque EX, and Conti-Fine BM (1995) A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. J Investig Dermatol 105:774-781.
15. Heatherton TF, Kozlowski LT, Frecker RC, and Fagerstrom KO (1991) The Fagerstrom TEST for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86:1119-1127.
16. Huston-Lyons D and Kornetsky C (1992) Effects of nicotine on the threshold for rewarding brain stimulation in rats. Pharmacol Biochem Behav 41:755-759.
17. Koob GF, Sanna PP, and Bloom FE (1998) Neuroscience of addiction. Neuron 21:467-476.
18. Lebargy F, Bennhammou K, Morin D, Zini R, Urien S, Brée F, Brignon J, Branellec A, and Lagrue G (1996) Tobacco smoking induces expression of very high affinity nicotine binding sites in blood polynuclear cells. Am J Respir Crit Care Med 153:1056-1063.
19. Lecoeur H, Ledru E, Prevost MC, and Gougeon ML (1997) Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. J Immunol Methods 209:111-123.
20. Lindstrom J (1997) Nicotinic acetylcholine receptors in health and disease. Mol Neurobiol 15:193-222.
21. Lowry OH, Rosebrough MJ, Farr AL, and Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
22. Macklin KD, Maus AD, Pereira EF, Albuquerque EX, and Conti-Fine BM (1998) Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther 287:435-439.
23. Mansvelder HD, Keath JR, and McGehee DS (2002) Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33:905-919.
24. Mansvelder HD and McGehee DS (2002) Cellular and Synaptic mechanisms of nicotine addiction. J Neurobiol 53:606-617.
25. Marubio LM, Arroyo-Jimenez MM, Cordero-Erausquin M, Léna C, Le Novère N, Kerchove d'Exaerde A, Huchet M, Damaj I, and Changeux JP (1999) Reduced nicotine-elicited antinociception in mice lacking the neuronal alpha-4 nicotinic receptor subunit. Nature (Lond) 398:805-810.
26. Maus AD, Pereira EF, Karachunski PI, Horton RM, Navaneetham D, Macklin K, Cortes WS, Albuquerque EX, and Conti-Fine BM (1998) Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol 54:779-788.
27. Murrin LC, Ferrer JR, Zeng WY, and Haley NJ (1987) Nicotine administration to rats: methodological considerations. Life Sci 40:1699-1708.
28. Orr-Urtreger A, Goldner FM, Saeki M, Lorenzo I, Goldberg L, De Biasi M, Dani JA, Patrick JW, and Beaudet AL (1997) Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci 17:9165-9171.
29. Paterson D and Nordberg A (2000) Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61:75-111.
30. Pauly JR, Marks MJ, Robinson SF, van de Kamp JL, and Collins AC (1996) Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing α4 or β2 mRNA levels. J Pharmacol Exp Ther 278:361-369.
31. Peng X, Gerzanich V, Anand R, Wang F, and Lindstrom J (1997) Chronic nicotine treatment up-regulates α3 and β7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol Pharmacol 51:776-784.
32. Peng X, Gerzanich V, Anand R, Whiting PJ, and Lindstrom J (1994) Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol 46:523-530.
33. Perry DC, Davila-Garcia MI, Stockmeiner CA, and Kellar KJ (1999) Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther 288:1549-1552.
34. Peto R, Lopez AD, Boreham J, Thun M, and Heath C (1992) Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 339:1268-1278.
35. Picciotto MR, Zoli M, Rimondini R, Léna C, Marubio LM, Merlo Pich E, Fuxe K, and Changeux JP (1998) Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature (Lond) 391:173-177.
36. Sanderson EM, Drasdo AL, McCrea K, and Wonnacott S (1993) Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific. Brain Res 617:349-352.
37. Sato KZ, Fujii T, Watanabe Y, Yamada S, Ando T, Kazuko F, and Kawashima K (1999) Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci Lett 266:17-20.
38. Scherer G and Richter E (1997) Biomonitoring exposure to environmental tobacco smoke (ETS): a critical reappraisal. Hum Exp Toxicol 16:449-459.
39. Shoaib M, Gommans J, Morley A, Stolerman IP, Grailhe R, and Changeux JP (2002) The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology 42:530-539.
40. Skok V, Kalashnik E, Koval L, Tsetlin V, Utkin Y, Changeux JP, and Grailhe R (2003) Functional nicotinic acetylcholine receptors are expressed in B lymphocyte-derived cell lines. Mol Pharmacol 64:885-889.
41. Sopori M (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2:372-377.
42. Stauderman KA, Mahaffy LS, Akong M, Velicelebi G, Chavez-Noriega LE, Crona JH, Johnson EC, Elliott KJ, Gillespie A, Reid RT, et al. (1998) Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations α2β4, α3β4 and α4β4 stably expressed in HEK293 cells. J Pharmacol Exp Ther 284:777-789.
43. Urien S (1995) Micropharm-K, microcomputer interactive program for the analysis and the simulation of pharmacokinetic processes. Pharm Res 12:1225-1230.
44. Wang F, Nelson M, Kuryatov A, Olale F, Cooper J, Keyser K, and Lindstrom J (1998) Chronic nicotine treatment up-regulates human α3β2 but not α3β4 acetylcholine receptors stably transfected in human embryonic kidney cells. Proc Natl Acad Sci USA 273:28721-28732.
45. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Yang H, Ulloa L, Al-Abed Y, et al. (2003) Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature (Lond) 421:384-388.